Michele Loughren
Psychiatric/Mental Health · Michigan City, INNPI 1881815231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 634 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 634 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lundbeck LLC$1K
- Teva Pharmaceuticals USA, Inc.$855
- Supernus Pharmaceuticals, Inc.$823
- Otsuka America Pharmaceutical, Inc.$761
- Johnson & Johnson$707
- plus $6K from 27 others
What the payments were for
- Food & beverage$11,13098%
- Education$2632%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $1,166 |
| Lundbeck LLC | 60 | $1,025 |
| Teva Pharmaceuticals USA, Inc. | 43 | $855 |
| Supernus Pharmaceuticals, Inc. | 40 | $823 |
| Otsuka America Pharmaceutical, Inc. | 40 | $761 |
| Johnson & Johnson | 42 | $707 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $686 |
| Alkermes, Inc. | 45 | $665 |
| Tris Pharma Inc | 40 | $663 |
| Neurocrine Biosciences, Inc. | 29 | $626 |
| Corium, LLC | 31 | $538 |
| Vanda Pharmaceuticals Inc. | 16 | $518 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $493 |
| Axsome Therapeutics, Inc. | 16 | $369 |
| E.r. Squibb & Sons, L.L.C. | 14 | $218 |
| Ironshore Pharmaceuticals Inc. | 8 | $166 |
| Noven Therapeutics, LLC | 7 | $127 |
| Bausch Health US, LLC | 7 | $118 |
| Idorsia Pharmaceuticals US Inc | 7 | $111 |
| Merck | 7 | $109 |
| OWP Pharmaceuticals, Inc. | 5 | $94 |
| Sunovion Pharmaceuticals Inc. | 5 | $89 |
| Almatica Pharma LLC | 5 | $86 |
| Adlon Therapeutics L.p. | 5 | $71 |
| Jazz Pharmaceuticals Inc. | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $39 |
| Indivior Inc. | 2 | $33 |
| Eisai Inc. | 2 | $28 |
| Avanir Pharmaceuticals, Inc. | 1 | $27 |
| Alfasigma USA, Inc. | 2 | $27 |
| Neuronetics, Inc. | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
How this compares
$11,393 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 33 | $260,126 |
| Austedo XrDeutetrabenazine | 22 | $229,216 |
| AustedoDeutetrabenazine | 24 | $162,839 |
| VraylarCariprazine Hcl | 47 | $97,812 |
| RexultiBrexpiprazole | 45 | $83,805 |
| Invega SustennaPaliperidone Palmitate | 22 | $79,104 |
| CaplytaLumateperone Tosylate | 20 | $44,174 |
| TrintellixVortioxetine Hydrobromide | 58 | $44,026 |
| Aripiprazole | 239 | $43,848 |
| AuvelityDextromethorphan Hbr/Bupropion | 21 | $41,102 |
| Lurasidone Hcl | 73 | $37,104 |
| SpravatoEsketamine Hcl | 26 | $36,447 |
| VyvanseLisdexamfetamine Dimesylate | 62 | $31,548 |
| LybalviOlanzapine/Samidorphan Malate | 20 | $30,507 |
| Paliperidone ErPaliperidone | 78 | $28,600 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $855 | $392,05446 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $626 | $260,12633 claims |
| Johnson & JohnsonInvega Sustenna, Spravato | $707 | $115,55148 claims |
| AbbVieVraylar | $1,166 | $97,81247 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $761 | $83,80545 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $493 | $75,574120 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $686 | $44,17420 claims |
| Axsome Therapeutics, Inc.Auvelity | $369 | $41,10221 claims |
| Alkermes, Inc.Lybalvi | $665 | $30,50720 claims |
| MerckBelsomra | $109 | $6,56711 claims |
| Almatica Pharma LLCSertraline Hcl | $86 | $3,861435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Michigan City
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
- Sharon ClevengerFort Wayne$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.